The Burke Neurological Institute (BNI) has received a five year award expected to total $45 million from the National Institutes of Health (NIH) to launch a large-scale, multi-center clinical trial to evaluate benfotiamine, a synthetic precursor of thiamine (vitamin B1), as a potentially effective therapy for mild Alzheimer’s disease (AD) or mild cognitive impairment (MCI).
In a summer camp-like setting from June 25-29, the Friel Lab hosted kids with cerebral palsy (CP) for the NIH-funded clinical trial “Bimanual Training & Transcranial Direct Current Stimulation (tDCS) on Hand Function in Children with Hemiplegia.”
On May 20th, the Burke Neurological Institute hosted the 3rd annual McDowell Symposium and Awards, an event that honored the legacy of Dr. Fletcher McDowell, the founder of BNI, and his enormous commitment to improving stroke treatment and care.
In this fifteen-minute video vignette, “Part 2: What Happens Now? Motor Recovery” you will gain an understanding of the network of the brain and motor function in the body, neuroplasticity, physical therapy, and current technology to help improve motor abilities.
Regeneron Westchester Science and Engineering Fair
On March 24th, Michelle Sosner, Christina Kelly, and Kalyna Raguso, three research volunteers from from the Burke Neurological Institute, received awards at the Regeneron Westchester Science and Eng
On Match Day, March 18th, Christopher Costa, a former Summer Scholars Student and Research Technician in the Willis Lab at the Burke Neurological Institute, matched for his residency for Internal Medicine at the University of Connecticut, School of Medicine beginning in June 2022.
